RxDoctor Payments Data

Karen Millett

Psychiatric/Mental Health · Provo, UTNPI 1134378334

Payments from drug & device makers

$802in general payments, 2019–2025

Across 42 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$146
  • Neurocrine Biosciences, Inc.$132
  • AbbVie$131
  • Otsuka America Pharmaceutical, Inc.$103
  • Indivior Inc.$50
  • Teva Pharmaceuticals USA, Inc.$47
  • plus $194 from 7 others

What the payments were for

  • Food & beverage$802100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$802 in reported general payments places this provider in the 60th percentile of 393 psychiatric/mental health providers in Utah.

See all psychiatric/mental health providers in Utah

Medicare billing

Part B allowed, 2024
$12,342
Medicare patients
30
Services billed
153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate266$771,450
AristadaAripiprazole Lauroxil42$115,748
IngrezzaValbenazine Tosylate11$83,076
VraylarCariprazine Hcl48$68,423
Abilify MaintenaAripiprazole30$66,246
RexultiBrexpiprazole29$39,509
AuvelityDextromethorphan Hbr/Bupropion33$32,856
FanaptIloperidone14$28,549
Clozapine297$12,682
Lurasidone Hcl42$8,817
TrintellixVortioxetine Hydrobromide19$8,707
Paliperidone ErPaliperidone45$6,818
Atomoxetine Hcl57$4,860
Hydroxyzine Hcl191$2,930
Quetiapine Fumarate230$2,256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$19$771,450266 claims
Alkermes, Inc.Aristada$146$115,74842 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$103$105,75559 claims
Neurocrine Biosciences, Inc.Ingrezza$132$83,07611 claims
AbbVieVraylar$131$68,42348 claims
Axsome Therapeutics, Inc.Auvelity$14$32,85633 claims
Vanda Pharmaceuticals Inc.Fanapt$39$28,54914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 393 psychiatric/mental health providers in Utah.

Other psychiatric/mental health in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →